Marimed Inc
OTC:MRMD
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Marimed Inc
OTC:MRMD
|
34.6m USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
291.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.7B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.2B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.3B USD |
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
90.6B GBP |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Marimed Inc
Glance View
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. The company is headquartered in Newton, Massachusetts and currently employs 260 full-time employees. The company went IPO on 2012-05-04. The firm develops, operates, manages, and optimizes facilities for the cultivation, production and dispensing of medicinal and recreational cannabis. The firm also licenses its brands of cannabis and hemp-infused products, along with other brands in domestic markets and overseas. The firm also provides its clients with ongoing regulatory, accounting, real estate, human resources, and administrative services. The company has its own brands of cannabis flower, concentrates, and precision-dosed products utilizing strains and formulations. The company markets its cannabis flowers and concentrates under the Nature’s Heritage brand; cannabis-infused chewable tables and powder drink mixes under the brand names Kalm Fusion and K Fusion; all natural fruit chews under the Betty’s Eddies brand; and brownies, cookies, and other social sweets under the Bubby’s Baked brand.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Marimed Inc is 38.3%, which is below its 3-year median of 42.3%.
Over the last 3 years, Marimed Inc’s Gross Margin has decreased from 49.2% to 38.3%. During this period, it reached a low of 38.3% on Oct 30, 2025 and a high of 49.2% on Aug 30, 2022.